11 December 2025

Long COVID Research Gets a Major Funding Boost

A Major National Investment in Post-Infection Science

In a major effort to deepen understanding of long COVID and related post-infection syndromes, the government of Germany has pledged €500 million (about US $580 million) to support research over the next decade. This funding will launch a National Decade Against Post-Infectious Diseases, spanning 2026 to 2036, with the goal of improving knowledge of conditions such as long COVID and chronic fatigue syndrome (also called ME/CFS), and accelerating the discovery of effective treatments.

Why It Matters

Long COVID has been widely recognized as a persistent and complex condition, where symptoms such as fatigue, cognitive impairment, and other multi-system issues can linger months or years after the initial SARS-CoV-2 infection. Similar post-infection syndromes, like ME/CFS, have historically received limited funding and scientific attention despite their significant impact on patients’ lives. The new investment aims to change that by providing stable, long-term support for research into the causes, mechanisms, diagnostics, and potential therapies for these conditions.

Focus on Science, Collaboration, and Innovation

Under the decade-long initiative, funds will be distributed to research institutions across Germany and potentially foster international collaboration. The aims include expanding clinical trials, improving biomarker and diagnostic research, supporting junior scientists entering the field, and enhancing understanding of both long COVID’s biological underpinnings and its overlap with other post-infection conditions. This comprehensive approach intends to build a stronger scientific infrastructure for tackling a class of diseases that have long been challenging to define and treat.

A Step Toward Better Care and Treatment

While the scientific community continues to make incremental advances in understanding long COVID, this substantial, strategic funding commitment reflects the urgency and importance of the issue both in Germany and globally. By investing in robust research and fostering interdisciplinary collaboration, health experts hope to uncover new therapeutic options, refine care strategies for affected patients, and potentially alleviate the long-term health burden of post-infection syndromes.